NIH-funded research R01 grant

Targeting brain inflammation after global brain injury from cardiac arrest

Official title: A Novel Therapeutic Strategy Targeting Neuroinflammation for Global Cerebral Ischemia Associated with Cardiac Arrest

Funded at Creighton University · NIH-11365149 · Data updated 2026-11-12

This grant tests a new treatment aimed at reducing brain inflammation after cardiac arrest to protect memory and thinking in people who survive a cardiac arrest.

More Cardiac Arrest research and trials

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionCreighton University
NIH-funded
Lab location1 site (Omaha, United States)
Project startAugust 15, 2024
Project endMay 31, 2029
Funding year2026
Award (this year)$426,656
NIH project number5R01NS134993-03
Project IDNIH-11365149 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates are individuals who have survived cardiac arrest with global cerebral ischemia and are at risk of cognitive impairment.

Less likely to help

Patients without evidence of hippocampal injury or those not at risk for neuroinflammation may derive less benefit.

What this research studies

If the brain doesn’t get oxygen during cardiac arrest, patients can have lasting memory and thinking problems. The researchers plan to study how dampening a specific inflammatory pathway (TREM1) may prevent nerve cells in a key brain area from dying and improve cognitive outcomes after the event. They will use RNA analysis and animal models to understand how this therapy changes brain gene activity and inflammation. The goal is to develop a treatment that works alongside emergency care to limit brain injury.

Why it matters

Potential benefit: If successful, this approach could reduce cognitive disabilities after cardiac arrest and improve survivors’ quality of life.

How similar studies have gone: Prior work suggests targeting neuroinflammation can modulate brain injury after ischemia, but this specific TREM1 pathway approach is exploratory.

Where this research is happening

  • Creighton University
    Omaha, United States
    Active

Researchers

  • Principal investigator: Hwang, Jee-Yeon — Creighton University
  • Study coordinator: Hwang, Jee-Yeon

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.